Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrovascular Responses to Acute Hypoperfusion
NCT06629077Phase 2Recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 2026
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prazosin, sponsored by University of Wisconsin–Madison. Started Feb 2026; status: recruiting.
02
Drugs
prazosin
Beyond the preview
Go deeper on NCT06629077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06629077.